Perıhan Ünak

727 total citations
70 papers, 589 citations indexed

About

Perıhan Ünak is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Perıhan Ünak has authored 70 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Perıhan Ünak's work include Radiopharmaceutical Chemistry and Applications (20 papers), Estrogen and related hormone effects (7 papers) and Orthopedic Infections and Treatments (5 papers). Perıhan Ünak is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (20 papers), Estrogen and related hormone effects (7 papers) and Orthopedic Infections and Treatments (5 papers). Perıhan Ünak collaborates with scholars based in Türkiye, United States and United Kingdom. Perıhan Ünak's co-authors include Fazilet Zümrüt Biber Müftüler, Fatma Yurt, Emin İlker Medine, Ayfer Yurt Kılçar, Kübra Durkan, Suna Tımur, Turan Karaca, Mustafa Cemek, Bilal Demir and Fırat Barış Barlas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomacromolecules and RSC Advances.

In The Last Decade

Perıhan Ünak

68 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perıhan Ünak Türkiye 14 205 133 94 74 70 70 589
Peri̇han Ünak Türkiye 16 299 1.5× 175 1.3× 114 1.2× 128 1.7× 103 1.5× 90 895
Emin İlker Medine Türkiye 15 197 1.0× 199 1.5× 82 0.9× 95 1.3× 149 2.1× 78 683
Ali Khalaj Iran 17 208 1.0× 287 2.2× 91 1.0× 154 2.1× 84 1.2× 93 975
Jinxin Li China 16 67 0.3× 220 1.7× 48 0.5× 81 1.1× 61 0.9× 67 775
Nagesh Bandi United States 12 104 0.5× 186 1.4× 93 1.0× 70 0.9× 121 1.7× 13 798
Phuong Tu Huynh South Korea 14 70 0.3× 139 1.0× 44 0.5× 72 1.0× 51 0.7× 20 523
Ismail Ibrahim Egypt 17 384 1.9× 183 1.4× 135 1.4× 114 1.5× 53 0.8× 99 817
Senthil Venkatachalam India 13 95 0.5× 130 1.0× 52 0.6× 48 0.6× 70 1.0× 52 589
Aruna Korde India 20 388 1.9× 161 1.2× 151 1.6× 156 2.1× 76 1.1× 68 875
Tomasz Skórka Poland 16 60 0.3× 133 1.0× 30 0.3× 20 0.3× 92 1.3× 33 594

Countries citing papers authored by Perıhan Ünak

Since Specialization
Citations

This map shows the geographic impact of Perıhan Ünak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perıhan Ünak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perıhan Ünak more than expected).

Fields of papers citing papers by Perıhan Ünak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perıhan Ünak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perıhan Ünak. The network helps show where Perıhan Ünak may publish in the future.

Co-authorship network of co-authors of Perıhan Ünak

This figure shows the co-authorship network connecting the top 25 collaborators of Perıhan Ünak. A scholar is included among the top collaborators of Perıhan Ünak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perıhan Ünak. Perıhan Ünak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Müftüler, Fazilet Zümrüt Biber, Emin İlker Medine, Özge Kozguş Güldü, et al.. (2020). Thymoquinone Glucuronide Conjugated Magnetic Nanoparticle for Bimodal Imaging and Treatment of Cancer as a Novel Theranostic Platform. Current Radiopharmaceuticals. 14(1). 23–36. 5 indexed citations
3.
Ünak, Perıhan, et al.. (2019). Analyzing of Production Conditions of 89Zr in the Particle Accelerator. SHILAP Revista de lepidopterología. 40(2). 388–395.
4.
Ünak, Perıhan, et al.. (2019). Determination of Grayanotoxin-III from in Rhodendron Ponticum And Mad Honey Samples by Liquid Chromatography−Mass Spectrometry. DergiPark (Istanbul University). 1(1). 1–21. 1 indexed citations
5.
Subramanian, Mahendran, et al.. (2016). A Pilot Study Into the Use of FDG-mNP as an Alternative Approach in Neuroblastoma Cell Hyperthermia. IEEE Transactions on NanoBioscience. 15(6). 517–525. 15 indexed citations
6.
Müftüler, Fazilet Zümrüt Biber, Ayfer Yurt Kılçar, & Perıhan Ünak. (2015). A perspective on plant origin radiolabeled compounds, their biological affinities and interaction between plant extracts with radiopharmaceuticals. Journal of Radioanalytical and Nuclear Chemistry. 306(1). 1–9. 18 indexed citations
7.
Güldü, Özge Kozguş, Perıhan Ünak, Emin İlker Medine, et al.. (2015). 131I Labeled Zinc Oxide Nanoparticles: Synthesis, Labeling with 131I and in Vitro Uptake Studies on U87-Mg Cells. Molecular Imaging and Radionuclide Therapy. 24(1). 42–43. 2 indexed citations
8.
Müftüler, Fazilet Zümrüt Biber, et al.. (2012). Anti toxic effect of broccoli extract on stannous dichloride toxicity. Acta Cirúrgica Brasileira. 27(9). 606–610. 4 indexed citations
9.
Kılçar, Ayfer Yurt, Fazilet Zümrüt Biber Müftüler, Perıhan Ünak, Çığır Biray Avcı, & Cumhur Gündüz. (2011). Diethylenetriamine Pentaacetic Acid Derivative of Toremifene and In Vitro Evaluation in Human Breast Cancer Cell Line MCF-7. Cancer Biotherapy and Radiopharmaceuticals. 26(1). 105–111. 2 indexed citations
11.
Ünak, Perıhan, et al.. (2011). L-Carnitine Protection Against Cisplatin Nephrotoxicity In Rats: Comparison with Amifostin Using Quantitative Renal Tc 99m DMSA Uptake. Molecular Imaging and Radionuclide Therapy. 20(1). 1–6. 13 indexed citations
12.
Ünak, Perıhan, Fatma Yurt, Fazilet Zümrüt Biber Müftüler, et al.. (2010). Radiolabeling of Morphine with 131 I and Its Biodistribution in Rats. Cancer Biotherapy and Radiopharmaceuticals. 25(4). 409–416. 6 indexed citations
13.
Ünak, Perıhan, et al.. (2010). Radiopharmaceutical model using 99mTc-DMSA to evaluate amifostine protection against cisplatin nephrotoxicity in rats. 19(3). 105–109. 3 indexed citations
14.
Kılçar, Ayfer Yurt, et al.. (2009). Synthesis of a Novel Antiestrogen Radioligand ( 99m Tc-TOR-DTPA). Cancer Biotherapy and Radiopharmaceuticals. 24(6). 707–716. 8 indexed citations
15.
Ünak, Perıhan, et al.. (2008). Metabolic comparison of radiolabeled aniline- and phenol-phthaleins with 131I. Nuclear Medicine and Biology. 35(4). 481–492. 7 indexed citations
16.
Ünak, Perıhan, et al.. (2007). Somatostatin with 99m Tc and Biodistribution Studies in Rats. Cancer Biotherapy and Radiopharmaceuticals. 22(6). 748–754. 5 indexed citations
17.
Ünak, Perıhan, et al.. (2007). Investigation of new bifunctional agents: D-Penicillamine. Journal of Radioanalytical and Nuclear Chemistry. 273(3). 641–647. 6 indexed citations
18.
Ünak, Perıhan, et al.. (2000). Determination of UO2(II), Th(IV) and Ce(III) Complexes Formed with Halogen and Nitro Derivatives of 8-Hydroxyquinoline. Journal of Radioanalytical and Nuclear Chemistry. 246(2). 323–326. 3 indexed citations
19.
Ünak, Perıhan, et al.. (1998). Labeling of Penicillamine di sulfide with technetium-99m. Applied Radiation and Isotopes. 49(7). 805–809. 7 indexed citations
20.
Ünak, Perıhan, et al.. (1991). Microscopic energy absorption in the colloid of thyroid follicles from Auger electrons of iodine-125. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 42(3). 291–295. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026